Alagille Syndrome Treatment Market, By Drug (Ursodeoxycholic Acid, Cholestyramine, Rifampicin, Late Stage Pipeline Drugs, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin Amer

Alagille Syndrome Treatment Market, By Drug (Ursodeoxycholic Acid, Cholestyramine, Rifampicin, Late Stage Pipeline Drugs, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)


Alagille syndrome is a genetic disorder that may affect many different parts of the body including the liver, heart, eyes, face, skeleton, blood vessels, and kidneys. A person with Alagille syndrome has fewer than the normal number of small bile ducts inside the liver. Bile ducts carry bile from the liver to the gallbladder for storage and then to the first part of the small intestine, also called the duodenum, for use in digestion. With fewer small bile ducts, less bile flows out of the liver. This condition is called cholestasis. As bile builds up in the liver, it may cause liver damage. Thus, the introduction of new drugs for the treatment of alagille syndrome in the market is expected to drive the growth of the global alagille syndrome treatment market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs with different approaches and platforms for the treatment of Alagille syndrome. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global alagille syndrome treatment market over the forecast period. For instance, on June 13, 2023, Ipsen Pharma, a global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved Bylvay (odevixibat) for the treatment of cholestatic pruritus in patients from 12 months of age with Alagille Syndrome (ALGS).

Key features of the study:
  • This report provides an in-depth analysis of the global alagille syndrome treatment market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global alagille syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie, Inc., Glenmark Pharmaceuticals Limited, Par Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., Sanofi S.A., Mylan N.V., Novartis International AG, Akorn, Inc., Albireo Pharma, Inc., Mirum Pharmaceuticals, Ipsen Pharma, and CANbridge Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global alagille syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alagille syndrome treatment market
Alagille Syndrome Treatment Market Detailed Segmentation:
  • By Drug:
  • Ursodeoxycholic Acid
  • Cholestyramine
  • Rifampicin
  • Late Stage Pipeline Drugs
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie, Inc.
  • Glenmark Pharmaceuticals Limited
  • Par Pharmaceuticals, Inc.
  • Mylan Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Mylan N.V.
  • Novartis International AG
  • Akorn, Inc.
  • Albireo Pharma, Inc.
  • Mirum Pharmaceuticals
  • Ipsen Pharma
  • CANbridge Pharmaceuticals, Inc.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Diagnosis & Treatment Overview
Key Developments
PEST Analysis
4. Global Alagille Syndrome Treatment Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Alagille Syndrome Treatment Market, By Drug, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Ursodeoxycholic Acid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Cholestyramine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Rifampicin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Late Stage Pipeline Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
6. Global Alagille Syndrome Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
7. Global Alagille Syndrome Treatment Market, By Region, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug, 2018-2030, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
AbbVie, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Glenmark Pharmaceuticals Limited
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Par Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Mylan Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Mylan N.V.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Novartis International AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Akorn, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Albireo Pharma, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Mirum Pharmaceuticals
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Ipsen Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
CANbridge Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 28 figures on “Global Alagille Syndrome Treatment Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings